A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic Arthritis

Clinical trial NCT05083078 · TERMINATED

Trial details

NCT number: NCT05083078
Sponsor: Janssen Research & Development, LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Arthritis, Psoriatic Healthy

Start date: 2021-11-04
Primary completion: 2022-07-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.